다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Achillion Pharmaceuticals Inc (ACHN)
Achillion Pharmaceuticals Inc (ACHN) 뉴스

ACHN

Achillion Pharmaceuticals (ACHN)

Achillion Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ACHN

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2020/02/15	06:55	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2020/02/15	03:29	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2020/02/13	00:27	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2020/02/12	21:58	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2020/02/10	21:34	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2020/02/07	20:11	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2020/02/03	20:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2020/02/03	20:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2020/02/03	20:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2020/02/03	20:00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2019/12/19	23:24	GlobeNewswire Inc.	Achillion Shareholders Approve Agreement to be Acquired by Alexion	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2019/12/10	00:00	GlobeNewswire Inc.	Achillion Reports Positive Data from Phase 2 Study of Danicopan (ACH-4471) in Combination with Eculizumab in PNH Patients who...	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2019/11/23	00:42	PR Newswire (US)	Moore Kuehn, PLLC Encourages Investors of SRC Energy, Inc. (SRCI), Achillion Pharmaceuticals, Inc. (ACHN), and Arotech Corpor...	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2019/11/19	21:30	GlobeNewswire Inc.	European Medicines Agency Grants PRIME Designation to Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients...	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2019/11/11	21:30	GlobeNewswire Inc.	Achillion Announces Clearance of Investigational New Drug Application for ACH-5228	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2019/11/08	06:20	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2019/11/08	06:18	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2019/11/08	06:08	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2019/11/07	21:30	GlobeNewswire Inc.	Achillion Reports Third Quarter 2019 Financial Results and Provides Corporate Update	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2019/11/06	23:07	GlobeNewswire Inc.	Achillion Announces Data Presentations at the 61st American Society of Hematology Annual Meeting	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2019/11/06	07:07	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (preliminary) (prem14a)	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2019/11/02	05:23	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/a)	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2019/10/19	06:14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2019/10/19	05:50	PR Newswire (US)	SHAREHOLDER ALERT: WeissLaw LLP Investigates Achillion Pharmaceuticals, Inc.	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2019/10/18	06:09	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2019/10/17	05:55	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2019/10/16	23:44	PR Newswire (US)	Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Achillion Pharmaceuticals, Inc. has obtained a Fair Price in it...	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2019/10/16	21:54	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2019/10/16	21:52	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ACHN	Achillion Pharmaceuticals Inc
2019/10/16	21:50	PR Newswire (US)	Achillion (ACHN) Alert: Johnson Fistel Investigates Proposed Sale of Achillion Pharmaceuticals; Are Shareholders Getting a Fa...	NASDAQ:ACHN	Achillion Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:ACHN

1 2 3 4 5 6 7 8 9 10 다음 >>

US Dollar vs Euro

Health Care Select Sector

Deutsche Telekom (QX)

Financial Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관